Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminium chlorohydrate is a group of water-soluble aluminium salts widely used as the active ingredient in over-the-counter antiperspirant cosmetic and pharmaceutical products. It is applied topically to the axillary skin to manage hyperhidrosis (excessive sweating) and general perspiration. The compound acts via a physical mechanism of action, dissolving in sweat or moisture on the skin surface to form a temporary gel-like plug within the ducts of the eccrine sweat glands, thereby mechanically blocking the release of sweat. Key clinical bioavailability studies conducted by TNO (commissioned by Cosmetics Europe) using a rare isotope 26Al microtracer approach demonstrated that systemic absorption of aluminium through the skin is extremely low (approximately 0.00052% to 0.012% of the applied dose), indicating negligible systemic exposure from normal antiperspirant use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium chlorohydrate.